Skip to content

Body composition, eating disorder psychopathology and psychological distress in anorexia nervosa

Body composition, eating disorder psychopathology and psychological distress in anorexia nervosa: a longitudinal study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN92626057
Enrollment
150
Registered
2013-12-16
Start date
2011-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia nervosa/body composition Mental and Behavioural Disorders Anorexia nervosa

Interventions

We recruited 50 female patients with a diagnosis of anorexia nervosa and 100 age and BMI matched healthy controls for an observational study. The interventions are weight restoration and cognitive beh

Sponsors

Villa Garda Hospital (Italy)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female patients aged 18?50 years 2. Diagnosis of anorexia nervosa 3. Body mass index (BMI) =17.5 kg/m² at time zero 4. BMI = 18.5 kg/m² at the end of the treatment

Exclusion criteria

Exclusion criteria: 1. Participants that do not satisfy inclusion criteria 2. Participants with active substance abuse, schizophrenia and other psychotic disorders

Design outcomes

Primary

MeasureTime frame
1. To assess the change in lean and fat masses and their distribution (using DXA) before and after complete weight restoration in AN patients. 2. To compare body composition and fat distribution (using DXA) of weight-restored AN patients with a healthy age- and post-treatment BMI-matched control group. All outcomes were collected at baseline and at the end of the treatment (20 weeks of treatment).

Secondary

MeasureTime frame
To assess the relationship between body composition patterns (using DXA), eating disorder psychopathology (using EDE) and general distress (using BSI) in AN patients. All outcomes were collected at baseline and at the end of the treatment (20 weeks of treatment).

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026